Evidence map›Paper›PMID 31844758›Full record

ArticleHeliyon2019

Towards a Göttingen minipig model of adult onset growth hormone deficiency: evaluation of stereotactic electrocoagulation method.

Laura Hvidsten Ørstrup, Laura Tvilling, Dariusz Orlowski, Hamed Zaer, Carsten Reidies Bjarkam, Pia von Voss, Pia Skårup Andersen, Berit Ø Christoffersen, Jens Christian Hedemann Sørensen, Torben Laursen and 3 more

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Laura Hvidsten ØrstrupGlobal Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark.
Laura TvillingCENSE Group, Department of Neurosurgery, Aarhus University Hospital and Department of Clinical Medicine, Aarhus University, Denmark.
Dariusz OrlowskiCENSE Group, Department of Neurosurgery, Aarhus University Hospital and Department of Clinical Medicine, Aarhus University, Denmark.
Hamed ZaerCENSE Group, Department of Neurosurgery, Aarhus University Hospital and Department of Clinical Medicine, Aarhus University, Denmark.
Carsten Reidies BjarkamDepartment of Neurosurgery, Aalborg University Hospital, Denmark.
Pia von VossGlobal Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark.
Pia Skårup AndersenGlobal Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark.
Berit Ø ChristoffersenGlobal Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark.
Jens Christian Hedemann SørensenCENSE Group, Department of Neurosurgery, Aarhus University Hospital and Department of Clinical Medicine, Aarhus University, Denmark.
Torben LaursenDepartment of Clinical Pharmacology, Aarhus University Hospital, Denmark.
Peter ThygesenGlobal Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark.
Jens LykkesfeldtDepartment of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
Andreas Nørgaard GludCENSE Group, Department of Neurosurgery, Aarhus University Hospital and Department of Clinical Medicine, Aarhus University, Denmark.
Aarhus University Hospital · DKNovo Nordisk (Denmark) · DKUniversity of Copenhagen · DKAalborg University Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdult onset growth hormone (GH) deficiency (AGDH) is a potentially underdiagnosed condition, caused by damage to the pituitary gland. AGHD is treated with growth hormone replacement therapy. A large variety of clinical symptoms and changes in the metabolic homeostasis can be observed and quantified. New large animal models are needed for future drug development. NEW

methodIn this study, we evaluate methods for a new large non-primate animal model of GH deficiency in post pubertal Göttingen Minipigs (minipig). Lesions in the pituitary gland were made by stereotaxic monopolar thermo-coagulation guided by magnetic resonance imaging (MRI), and pituitary function was evaluated using insulin tolerance test (ITT) with measurements of growth hormone secretion induced by hypoglycemia.

resultsLesions were successfully applied to the pituitary gland without any damage to surrounding tissue including the hypothalamus, which was confirmed by post-operative MRI and post mortem histology. Plasma levels of GH during ITT showed no decrease in secreted levels one week after surgery compared to levels obtained before surgery. COMPARISON WITH EXISTING

methodsCompared to other GH insufficiency models, eloquent brain tissue is spared. Furthermore, alternatively to rodent models, a large animal model would allow the use of human intended equipment to evaluate disease. Using the minipig avoids social, economical and ethical issues, compared with primates.

conclusionThe lesions did not remove all GH production, but proof of concept is demonstrated. In addition, the ITT is presented as a safe and efficient method to diagnose GH deficiency in minipigs.

Indexed as

EndocrinologyGöttingen minipigGrowth hormone deficiencyHypophysectomyLarge animal modellingMetabolic disorderMetabolismNeuroscienceNeurosurgeryPhysiologyStereotaxic surgerySurgerySus scrofa

Identifiers

PMID31844758
PMCPMC6895662
OpenAlexW2989664650

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.